Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
Published 29 July 2008, doi:10.1136/bmj.39563.581377.80
Cite this as: BMJ 2008;337:a428
Jane Gibbins, specialist registrar and clinical research fellow, Gaye Senior Smith, clinical nurse specialist, Karen Forbes, consultant and macmillan professorial teaching fellow
1 Department of Palliative Medicine, Bristol Haematology and Oncology Centre, Bristol BS2 8ED
Correspondence to: J Gibbins janegibbins@hotmail.com
A "palliative care" label should not prevent life saving treatment for an illness with reversible cause
| The first 150 words of the full text of this article appear below. |
The word palliative is used in different ways in different contexts. Lack of clarity about its meaning can lead to confusion about the role of palliative care teams and the appropriateness of active management in a patients care.
A 60 year old woman was diagnosed with a rare haemangioendothelioma of the lung with liver, bone, and lung metastases in April 2004. She was referred to the outpatient clinic run by our specialist hospital palliative care team in December 2006 by her respiratory physician. Although she was extremely independent, she had severe right upper quadrant pain, which was consistent with liver capsular distension secondary to liver metastases. She had tried non-steroidal anti-inflammatory drugs and steroids with no effect. Her pain responded to opioids. Her morphine was increased, and pain was controlled by 550 mg modified release morphine twice daily, with no opioid side effects.
She remained stable with no changes in
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
StumbleUpon
Technorati What's this?
Read all Rapid Responses